Let's talk medical research

Is there a connection between kidney disease, cardiovascular disease, and diabetes? What’s exciting about upcoming kidney disease clinical trials? Why is diversity in the kidney disease clinical research space so important? We spoke with Michael Spigler, Vice President of Patient Services and Kidney Disease Education at the American Kidney Fund (AKF) to learn more about AKF’s mission, what ...

This is a reprint of an article originally written by Alexandra Mulvey and published on our partner JDRF’s blog. The piece focuses on Anastasia Albanese-O’Neill, Ph.D., ARNP, CDCES’ excitement about this new role and why clinical trials are the only way to find treatments that work.

Celebrating its 13th year, SCOPE Summit took place from February 7-10, 2022 in Orlando, Florida. This year’s summit was hybrid, but with many making the journey to the in-person event, it was a great opportunity to see familiar faces away from the veil of our screens and devices. The work that the clinical research community does is in a state of transition that has been accelerated due to the ...

Patient recruitment is the most expensive and difficult part of a clinical trial, with recruitment costs representing 40% of the total budget.

If you’re interested in joining a clinical trial, one of the first places anyone will tell you to look is ClinicalTrials.gov, a database of privately and publicly funded clinical studies conducted around the world. Everyone has access to the key details of clinical trials listed on ClinicalTrials.gov, where you can see eligibility criteria. However, inclusion and exclusion criteria have become ...

Are you facing clinical trial patient recruitment challenges? Technology can help. There are many digital solutions that improve the recruitment process, from finding patients to prescreening and enrolling them into trials. Consider these helpful ways technology can improve the patient experience and accelerate enrollment into your trial, and take a look at our list of clinical trial patient ...

Peripheral artery disease (PAD) is a narrowing or blockage of the vessels (peripheral arteries) that carry blood away from the heart to other parts of the body. The most common form of PAD reduces blood flow from the heart to the legs and feet. PAD is primarily caused by atherosclerosis, which is the buildup of fatty plaque in the arteries that narrows and blocks them in the heart, brain, arms, ...

Antidote’s new podcast, Talk of the Towne, focuses on the ultimate sweet spot: that special place where science and patients converge. Our host, Rich Towne, was trained in pharmacy and currently works in Clinical Informatics at Antidote. In each episode, Rich welcomes a new guest from an organization with which Antidote is working, and takes an in-depth look at particular therapeutic areas, ...

Sometimes pharma professionals and researchers tell us that they didn't get the results they wanted from using social media for clinical trial recruitment. Patients responded to ads, they say, but didn't end up taking the next step. We've also heard that their social media referrals weren't ultimately eligible for the trial or that they lived too far from research sites. Then there's the concern ...

A stroke is an event that affects the arteries of the brain. When a blood vessel that brings blood to the brain gets blocked or bursts, a stroke occurs. The area of the brain impacted by a stroke can’t get the nutrients and oxygen it needs, causing nerve cells to lose their functionality.